Deltex Medical Group PLC Holding(s) in Company
20 Januar 2025 - 5:28PM
RNS Regulatory News
RNS Number : 0090U
Deltex Medical Group PLC
20 January 2025
|
|
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN
SHARESi
|
|
|
|
|
1.
Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii
|
Deltex
Medical Group Plc
|
|
2
Reason for the notification (please
tick the appropriate box or boxes):
|
|
An acquisition or disposal of voting
rights
|
ü
|
|
An acquisition or disposal of
qualifying financial instruments which may result in the
acquisition of shares already issued to which voting rights are
attached
|
|
|
An acquisition or disposal of
instruments with similar economic effect to qualifying financial
instruments
|
|
|
An event changing the breakdown of
voting rights
|
|
|
Other (please specify):
|
|
|
|
3.
Full name of person(s) subject to the
notification obligation: iii
|
Bottomley
Family
|
|
4.
Full name of shareholder(s)
(if
different from 3.):iv
|
|
|
5.
Date of the transaction and date on
which the threshold is crossed or
reached: v
|
20.01.25
|
|
6.
Date on which issuer notified:
|
20.01.25
|
|
7.
Threshold(s) that is/are crossed or
reached: vi,
vii
|
3%
|
|
|
|
|
| |
|
8.
Notified details:
|
|
A:
Voting rights attached to shares viii, ix
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering
transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
%
of voting rights x
|
|
Direct
|
Direct xi
|
Indirect xii
|
Direct
|
Indirect
|
|
|
55,100,000
|
55,100,000
|
60,000,000
|
60,000,000
|
0
|
3.2%
|
0
|
|
|
|
|
|
B:
Qualifying Financial Instruments
|
|
Resulting situation after the triggering
transaction
|
|
Type
of financial
instrument
|
Expiration
date xiii
|
Exercise/
Conversion Period xiv
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of
voting
rights
|
|
|
|
|
|
|
|
|
|
C:
Financial Instruments with similar economic effect to Qualifying
Financial Instruments xv,
xvi
|
|
Resulting situation after the triggering
transaction
|
|
Type
of financial
instrument
|
Exercise price
|
Expiration date xvii
|
Exercise/
Conversion period xviii
|
Number of voting rights instrument refers to
|
% of
voting rights xix,
xx
|
|
|
|
|
|
|
Nominal
|
Delta
|
|
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
60,000,000
|
3.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
9.
Chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held, if
applicable: xxi
|
|
|
|
|
|
Proxy Voting:
|
|
10.
Name of the proxy holder:
|
|
|
11.
Number of voting rights proxy holder will cease
to hold:
|
|
|
12.
Date on which proxy holder will cease to hold
voting rights:
|
|
|
|
|
13. Additional information:
|
|
|
14.
Contact name:
|
H S Bottomley
|
|
15.
Contact telephone number:
|
07774444134
|
|
|
| |
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
HOLEAKFEAADSEFA
Deltex Medical (LSE:DEMG)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Deltex Medical (LSE:DEMG)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
